Ready To Welcome To...
Health Care: Drugs
Forest Laboratories Inc. (FRX: NYSE)
$39.23 -0.30 | -0.76%
05/24/13 - 04:03 PM ET
Portfolios with FRX
- Portfolio NameUser Type
- ProCarl Icahn
- UserMike Fatah's Companies with...
- ContributorStocks With Big Insider Buy...
- ContributorPharmaceutical Short Squeez...
- ContributorEarnings Short Squeeze Play...
- UserSm. Magic July 5 13
- UserLong Term Stock Picks
- UserRikedom
- Userjohnnystocks
- ProRichard Pzena - Pzena Inves...
Latest FRX Headlines from TheStreet
- Today's Drugs Industry Featured Laggard: Forest Laboratories Inc. (FRX) 04.16.13 | 05:04 pm
- Notable Two Hundred Day Moving Average Cross - FRX 04.16.13 | 04:04 pm
- 5 Stocks Pushing The Drugs Industry Downward 04.15.13 | 01:04 pm
- Forest Laboratories Becomes #183 Most Shorted S&P 500 Component, Replacing Allergan 04.10.13 | 03:04 pm
- Ziopharm Considers Options After Drug Failure 03.27.13 | 11:03 am
- Stock Futures Slide as Traders Eye Earnings 01.15.13 | 09:01 am
- Before the Bell, January 15
01.15.13 | 08:01 am - Forest Reaches New 52-Week High (FRX) 01.11.13 | 09:01 am
- Analysts' Actions: RIMM AIG AOL JCP FRX 01.11.13 | 09:01 am
- Forest Rises On Unusually High Volume (FRX) 11.30.12 | 04:11 pm
Press Releases for FRX
- Trevena, Inc. And Forest Laboratories Announce A Collaborative Agreement For Development Of TRV027 For The Treatment Of Acute Heart Failure - PR Newswire 05.09.13 | 06:05 am
- From Perspectives To Struggles, Alzheimer's Family Caregivers Find Strength In Sharing - PR Newswire 02.05.13 | 10:02 am
- Forest Laboratories, Inc. Reports Fiscal Year 2013 Third Quarter Earnings - Business Wire 01.15.13 | 07:01 am
- Forest Laboratories, Inc. Announces Additional Settlement Agreement In BYSTOLIC® Patent Litigation - Business Wire 01.03.13 | 08:01 am
- Forest Laboratories, Inc. Sets Date And Conference Call For Fiscal 2013 Third Quarter Earnings - Business Wire 01.02.13 | 04:01 pm
- FACT SHEET -- Chronic Idiopathic Constipation - Business Wire 12.17.12 | 08:12 am
- Forest Laboratories And Almirall Announce Commercial Availability Of Tudorza™ Pressair™ In US Pharmacies - Business Wire 12.11.12 | 02:12 am
- Forest Laboratories, Inc. To Present Cariprazine Results From A Phase 3 Trial And Two Pharmacology Studies At The American College Of Neuropsychopharmacology (ACNP) Annual Meeting - Business Wire 12.03.12 | 05:12 pm
- Forest Laboratories, Inc. Announces Additional Settlement Agreements In BYSTOLIC® Patent Litigation - Business Wire 11.28.12 | 04:11 pm
- Forest Laboratories Submits New Drug Application For Cariprazine For The Treatment Of Both Schizophrenia And Manic Or Mixed Episodes Associated With Bipolar I Disorder - Business Wire 11.28.12 | 02:11 am
Partner Headlines for FRX
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Barron's Recap (3/23/13): World's Best CEOs - Benzinga 03.24.13 | 01:03 pm
- NIRI Appoints Charles Triano to Board of Directors - Benzinga 03.20.13 | 09:03 am
- UPDATE: Credit Suisse Raises PT to $44 on Forest Laboratories on Positive Linzess Survey - Benzinga 03.15.13 | 01:03 pm
- EU Approval for Ironwood's Constella - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- 3 Undervalued Healthcare Stocks Being Sold By Hedge Funds - Seeking Alpha 11.29.12 | 09:11 am
- Data on Pfizer's Lyrica - Analyst Blog - Zacks 11.19.12 | 07:11 pm
- For NovaBay, Simplicity Is The Father Of Invention - Seeking Alpha 11.12.12 | 09:11 am
- Earnings Scorecard: Forest Labs - Analyst Blog - Zacks 10.26.12 | 06:10 pm
- Pre-Market Earnings Report for October 16, 2012 : JNJ, KO, UNH, GS, PNC, STT, GWW, OMC, MAT, FRX, CBSH, DPZ - NASDAQ 10.15.12 | 08:10 pm
